HAEMONETICS CORP Quarterly Deferred Tax Assets, Gross in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Haemonetics Corp quarterly Deferred Tax Assets, Gross history and growth rate from Q1 2011 to Q1 2024.
  • Haemonetics Corp Deferred Tax Assets, Gross for the quarter ending March 30, 2024 was $105M, a 16.5% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $105M +$14.9M +16.5% Mar 30, 2024 10-K 2024-05-20
Q1 2023 $90.4M +$5.04M +5.91% Apr 1, 2023 10-K 2024-05-20
Q1 2022 $85.3M -$8.84M -9.39% Apr 2, 2022 10-K 2023-05-22
Q1 2021 $94.2M +$39.2M +71.2% Apr 3, 2021 10-K 2022-05-25
Q1 2020 $55M +$19.5M +54.8% Mar 28, 2020 10-K 2021-05-26
Q1 2019 $35.5M -$4.47M -11.2% Mar 30, 2019 10-K 2020-05-20
Q1 2018 $40M -$19M -32.2% Mar 31, 2018 10-K 2019-05-22
Q1 2017 $59M -$7.02M -10.6% Apr 1, 2017 10-K 2018-05-23
Q1 2016 $66M +$16.2M +32.5% Apr 2, 2016 10-K 2017-05-24
Q1 2015 $49.9M +$61.2M Mar 28, 2015 10-K 2016-06-01
Q1 2014 -$11.3M +$1.79M +13.7% Mar 29, 2014 10-K 2015-05-22
Q1 2013 -$13.1M -$939K -7.74% Mar 30, 2013 10-K 2014-05-22
Q1 2012 -$12.1M -$7.96M -190% Mar 31, 2012 10-K 2013-05-20
Q1 2011 -$4.18M Apr 2, 2011 10-K 2012-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.